Drug intelligence / Profile preview

cordyceps cicadae ethanolic extract

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Cordyceps cicadae ethanolic extract (CCM-EtOH) is an extract derived from the mycelia of *Cordyceps cicadae*, a well-known traditional Chinese herbal medicine. It is obtained through lyophilization and extraction with ethanol. Preclinical studies in a steroid-induced rat model of glaucoma have shown that CCM-EtOH can significantly lower intraocular pressure (IOP) and exhibits antioxidant activities. Its efficacy in IOP reduction was observed to be less than that of the aqueous extract (CCM-DW) in the same study. The antioxidant effects are evidenced by decreases in malondialdehyde and lactate dehydrogenase levels, and increases in catalase, superoxide dismutase, and glutathione peroxidase levels.

Other names: CCM-EtOH

Beyond the preview

Go deeper on cordyceps cicadae ethanolic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cordyceps cicadae ethanolic extract.

Explore the full profile